AP2119A - tor and an angiotensin-converting enzyme inhibitor, and pharmaceutical compositions containing it New association of a sinus node if current inhibi - Google Patents

tor and an angiotensin-converting enzyme inhibitor, and pharmaceutical compositions containing it New association of a sinus node if current inhibi

Info

Publication number
AP2119A
AP2119A AP2006003859A AP2006003859A AP2119A AP 2119 A AP2119 A AP 2119A AP 2006003859 A AP2006003859 A AP 2006003859A AP 2006003859 A AP2006003859 A AP 2006003859A AP 2119 A AP2119 A AP 2119A
Authority
AP
ARIPO
Prior art keywords
inhibi
angiotensin
tor
current
pharmaceutical compositions
Prior art date
Application number
AP2006003859A
Other languages
English (en)
Other versions
AP2006003859A0 (en
Inventor
Benatar Vidal
Guy Lerebours-Pigeonniere
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36685870&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP2119(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of AP2006003859A0 publication Critical patent/AP2006003859A0/xx
Application granted granted Critical
Publication of AP2119A publication Critical patent/AP2119A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
AP2006003859A 2005-12-21 2006-12-18 tor and an angiotensin-converting enzyme inhibitor, and pharmaceutical compositions containing it New association of a sinus node if current inhibi AP2119A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0513006A FR2894825B1 (fr) 2005-12-21 2005-12-21 Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent

Publications (2)

Publication Number Publication Date
AP2006003859A0 AP2006003859A0 (en) 2006-12-31
AP2119A true AP2119A (en) 2010-04-21

Family

ID=36685870

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2006003859A AP2119A (en) 2005-12-21 2006-12-18 tor and an angiotensin-converting enzyme inhibitor, and pharmaceutical compositions containing it New association of a sinus node if current inhibi

Country Status (42)

Country Link
US (2) US20070142355A1 (es)
EP (2) EP1800678B1 (es)
JP (2) JP4705564B2 (es)
KR (2) KR100907583B1 (es)
CN (1) CN101015557B (es)
AP (1) AP2119A (es)
AR (1) AR058574A1 (es)
AT (1) ATE508742T1 (es)
AU (1) AU2006252210B2 (es)
BR (1) BRPI0605517A (es)
CA (1) CA2571644C (es)
CO (1) CO5790168A1 (es)
CR (1) CR8820A (es)
CY (1) CY1111575T1 (es)
DK (1) DK1800678T3 (es)
EA (1) EA011253B1 (es)
ES (1) ES2366570T3 (es)
FR (1) FR2894825B1 (es)
GE (1) GEP20094604B (es)
GT (1) GT200600522A (es)
HK (1) HK1106444A1 (es)
HR (1) HRP20110532T1 (es)
IL (1) IL180204A (es)
JO (1) JO2699B1 (es)
MA (1) MA28723B1 (es)
ME (1) ME01958B (es)
MX (1) MXPA06014885A (es)
MY (1) MY146956A (es)
NO (1) NO337640B1 (es)
NZ (1) NZ552221A (es)
PE (2) PE20110116A1 (es)
PL (1) PL1800678T3 (es)
PT (1) PT1800678E (es)
RS (1) RS51731B (es)
SA (1) SA06270480B1 (es)
SG (2) SG173243A1 (es)
SI (1) SI1800678T1 (es)
TW (1) TWI369206B (es)
UA (1) UA86417C2 (es)
UY (1) UY30023A1 (es)
WO (1) WO2007077327A1 (es)
ZA (1) ZA200610824B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2894825B1 (fr) * 2005-12-21 2010-12-03 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
FR2920772B1 (fr) * 2007-09-11 2009-10-23 Servier Lab Association entre un anti-atherothrombotique et un inhibiteur de l'enzyme de conversion de l'angiotensine
FR2927538B1 (fr) * 2008-02-14 2010-02-19 Servier Lab Association d'un inhibiteur du courant if sinusal et d'un beta-bloquant.
CN101564394B (zh) * 2008-04-21 2010-12-15 鲁南制药集团股份有限公司 含有伊伐布雷定和曲美他嗪的药物组合物
FR2961105B1 (fr) * 2010-06-15 2013-02-08 Servier Lab Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque
WO2013116738A1 (en) * 2012-02-03 2013-08-08 Cardeus Pharmaceuticals, Inc. Drug formulations
FR3050380B1 (fr) 2016-04-20 2020-07-10 Les Laboratoires Servier Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains.

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001078699A2 (de) * 2000-04-13 2001-10-25 Boehringer Ingelheim Pharma Kg Verwendung von bradycardica bei der behandlung von mit hypertrophie einhergehenden myocarderkrankungen und neue arzneimittelkombinationen
EP1362590A1 (en) * 2002-07-25 2003-11-19 Boehringer Ingelheim Pharma GmbH & Co.KG Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4508729A (en) * 1979-12-07 1985-04-02 Adir Substituted iminodiacids, their preparation and pharmaceutical compositions containing them
DE3736866A1 (de) * 1987-10-30 1989-05-11 Thomae Gmbh Dr K Mittel zur behandlung des bluthochdrucks und der herzinsuffizienz
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
WO2002100328A2 (en) * 2001-06-08 2002-12-19 Ortho-Mcneil Pharmaceutical, Inc. Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels
AR036187A1 (es) * 2001-07-24 2004-08-18 Adir Un proceso para la preparacion de perindopril, compuestos analogos y sus sales, compuesto intermediario 2,5-dioxo-oxazolidina y proceso para preparar un intermediario
WO2003024457A1 (fr) * 2001-09-11 2003-03-27 Asahi Kasei Kabushiki Kaisha Composition medicinale pour la prevention ou le traitement des troubles vasculaires cerebraux et de la cardiopathie
FR2834896B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'ivabradine
FR2838648B1 (fr) * 2002-04-18 2004-05-21 Servier Lab Nouveau sel de perindopril et les compositions pharmaceutiques qui le contiennent
FR2882554B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme critalline beta d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882553B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline beta du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882556B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline gamma d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882555B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline gamma du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2894825B1 (fr) * 2005-12-21 2010-12-03 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001078699A2 (de) * 2000-04-13 2001-10-25 Boehringer Ingelheim Pharma Kg Verwendung von bradycardica bei der behandlung von mit hypertrophie einhergehenden myocarderkrankungen und neue arzneimittelkombinationen
EP1362590A1 (en) * 2002-07-25 2003-11-19 Boehringer Ingelheim Pharma GmbH & Co.KG Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure

Also Published As

Publication number Publication date
EP2298297A1 (fr) 2011-03-23
AP2006003859A0 (en) 2006-12-31
FR2894825A1 (fr) 2007-06-22
WO2007077327A1 (fr) 2007-07-12
PT1800678E (pt) 2011-07-12
AR058574A1 (es) 2008-02-13
EP1800678A1 (fr) 2007-06-27
SG133545A1 (en) 2007-07-30
UY30023A1 (es) 2007-01-31
ES2366570T3 (es) 2011-10-21
KR100907583B1 (ko) 2009-07-14
PL1800678T3 (pl) 2011-08-31
RS51731B (en) 2011-10-31
MA28723B1 (fr) 2007-07-02
TWI369206B (en) 2012-08-01
NO337640B1 (no) 2016-05-23
IL180204A (en) 2014-02-27
GEP20094604B (en) 2009-02-10
DK1800678T3 (da) 2011-08-15
CR8820A (es) 2007-08-28
SG173243A1 (en) 2011-08-29
CN101015557A (zh) 2007-08-15
EA011253B1 (ru) 2009-02-27
KR20090047424A (ko) 2009-05-12
FR2894825B1 (fr) 2010-12-03
SA06270480B1 (ar) 2011-02-23
AU2006252210A1 (en) 2007-07-05
IL180204A0 (en) 2008-01-20
MXPA06014885A (es) 2009-02-11
BRPI0605517A (pt) 2007-10-16
SI1800678T1 (sl) 2011-08-31
JP2011079854A (ja) 2011-04-21
EP1800678B1 (fr) 2011-05-11
HK1106444A1 (en) 2008-03-14
CN101015557B (zh) 2010-12-08
ATE508742T1 (de) 2011-05-15
CA2571644A1 (fr) 2007-06-21
NZ552221A (en) 2008-05-30
JP4705564B2 (ja) 2011-06-22
TW200744608A (en) 2007-12-16
JP2007169283A (ja) 2007-07-05
PE20110116A1 (es) 2011-03-02
GT200600522A (es) 2007-07-25
CO5790168A1 (es) 2007-08-31
HRP20110532T1 (hr) 2011-08-31
JO2699B1 (en) 2013-03-03
EA200602155A1 (ru) 2007-08-31
US20120196850A1 (en) 2012-08-02
ME01958B (me) 2011-10-31
US20070142355A1 (en) 2007-06-21
ZA200610824B (en) 2008-06-25
MY146956A (en) 2012-10-15
CY1111575T1 (el) 2015-10-07
NO20065905L (no) 2007-06-22
AU2006252210B2 (en) 2012-04-26
KR20070066921A (ko) 2007-06-27
PE20071004A1 (es) 2007-11-17
UA86417C2 (ru) 2009-04-27
CA2571644C (fr) 2011-03-08

Similar Documents

Publication Publication Date Title
IS7717A (is) Pýrídasínónafleiður sem PDF4-hemlar
IL231576A0 (en) Adamantyl acetamide derivatives as 11-beta-hydroxysteroid dehydrogenase type 1 enzyme inhibitors
AP2119A (en) tor and an angiotensin-converting enzyme inhibitor, and pharmaceutical compositions containing it New association of a sinus node if current inhibi
IL184329A0 (en) Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
IS7509A (is) Þíoxantínafleiður sem mergperoxídasatálmar
AU2003201595A1 (en) Fragrance compositions
ZA200609946B (en) Adamantyl-acetamide derivatives as inhibitor of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
HK1106442A1 (en) Association of a sinus node if, current inhibitor and a calcium inhibitor, and pharmaceutical compositions containing it
AU2003217916A8 (en) Stable formulations of angiotensin converting enzyme (ace) inhibitors
WO2009066035A3 (fr) Association entre un anti-atherothrombotique et un inhibiteur de l'enzyme de conversion de l'angiotensine
MX2009001590A (es) Asociacion de un inhibidor de corriente sinusal if y de un beta-bloqueante.
GB0225854D0 (en) Inhibitors of complement activation
AU2003298798A1 (en) New class of laundry compositions
GB0329998D0 (en) Enzyme inhibitors
GB0313814D0 (en) Enzyme inhibitors
GB0312240D0 (en) Enzyme inhibitors
GB0306188D0 (en) Enzyme inhibitors
AU2003217491A1 (en) Phenanthridinones as parp inhibitors